FADS2 and liver cancer: They showed that in HCC, FADS2 uses palmitate like SCD but produces sapienate (instead of palmitoleate), a monounsaturated fatty acid produced in sebaceous gland that will be incorporated into the phospholipids in the membrane of the liver cancer cell to adapt its needs to survive and to proliferate [88].